Tryton Medical Receives CE-mark for the Left Main Indication

Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, announced that it has received CE Mark for the treatment of Left Main Coronary artery disease.



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1brcCt1

via IFTTT